Top Markets
#1 Akedo Akedo +62.25%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.06%
#4 Velvet Velvet +40.81%
#5 Black Phoenix Black Phoenix +34.48%
#6 τemplar τemplar +27.84%
#7 Ribbita by Virtuals Ribbita by Virtuals +20.04%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +18.68%
#9 Bitway Bitway +17.34%
#10 Cap Cap +16.41%
Coin of the day
Akedo Akedo
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Entheon Biomedical Corp. Entheon Biomedical Corp.

Entheon Biomedical Corp.

ENBI
Rang in Aktien #38407
Entheon Biomedical Corp. functions as a biotechnology firm focused on the... Entheon Biomedical Corp. functions as a biotechnology firm focused on the research and development of novel pharmaceuticals. The company is actively involved in pioneering and introducing to market psychedelic therapeutic products, specifically those derived from N,N-dimethyltryptamine (DMT), with the aim of combating addiction and various substance use disorders. Its services are provided to medical doctors, healthcare facilities, and accredited psychiatrists across Canada, the United States, and the European Union. Entheon Biomedical Corp.'s primary operations are based in Vancouver, Canada.
Aktienkurs
$0.0719818
Zuletzt synchronisiert: 2026-01-15
Marktkapitalisierung
$997.59K
Veränderung (1 Tag)
-0.09%
Veränderung (1 Jahr)
4.67%
Land
CA
Handel Entheon Biomedical Corp. (ENBI)

Kategorie

Healthcare
Kursverlauf für Entheon Biomedical Corp. (ENBI)
Höchster Schlusskurs: $0.07 am 2026-01-01

Niedrigster Schlusskurs: $120.80 am 2015-05-01
Kursverlauf der Aktie von Entheon Biomedical Corp. von 2015 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -5.82%
2025 -40.09%
2024 58.44%
2023 -61.07%
2022 -94.22%
2021 -53.20%
2020 293.75%
2019 24.71%
2018 -99.04%
2017 1.22%
2016 83.36%
2015 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 29.45%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.68%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE